Advertisement

Kollagen-Implantation

  • Johannes Petres
  • Rainer Rompel

Zusammenfassung

Die Implantation von hochgereinigtem bovinen Kollagen bietet die Möglichkeit , fehlendes oder beschädigtes körpereigenes Kollagen zu ersetzen. Die gegenwärtig verwendeten Präparate sind nach der Injektion lagestabil und induzieren die Besiedelung durch körpereigene Bindegewebszellen. Früher verwendete Präparate hatten den Nachteil von häufigen Fremdkörperreaktionen und tropften zum Teil in andere Geweberegionen ab. Voraussetzung für die geringe Antigenität der derzeit verwendeten Materialien soll die enzymatische Abspaltung der N- bzw. C-terminalen Peptidketten sein.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Kollagen-Implantate

  1. Barr RJ, Stegman SJ (1984) Delayed skin test reaction to injectable collagen implant (Zyderm). The histopathologic comparative study. J Am Acad Dermatol 10: 652–658PubMedCrossRefGoogle Scholar
  2. Clark DP, Hanke CW, Swanson NA (1989) Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol 21: 992–998PubMedCrossRefGoogle Scholar
  3. Cooperman L, Michaeli D (1984) The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients. J Am Acad Dermatol 10: 647–651PubMedCrossRefGoogle Scholar
  4. Ellingsworth LR, De Lustro F, Brennan JE, Sawamura S, McPherson J (1986) The human immune response to reconstituted bovine collagen. J Immunol 136: 877–882PubMedGoogle Scholar
  5. Elson ML (1988) Clinical assessment of Zyplast implant: a year of experience for soft tissue contour correction. J Am Acad Dermato118: 707–713Google Scholar
  6. Elson ML (1992) Soft tissue augmentation of periorbital fine lines and the orbital groove with Zyderm-I and fine-gauge needles. J Dermatol Surg Onco118: 779–782Google Scholar
  7. Elson ML (1993) Dermal filler materials. Dermatol Clin 11: 361–367PubMedGoogle Scholar
  8. Gormley DE, Eremia S (1990) Quantitative assessment of augmentation therapy. J Dermatol Surg Oncol 16: 1147–1151PubMedCrossRefGoogle Scholar
  9. Greenbaum SS (1991) The treatment of chondrodermatitis nodularis chronica helicis with injectable collagen. Int J Dermatol 30: 291–294PubMedCrossRefGoogle Scholar
  10. Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ (1991) Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 25: 319–326PubMedCrossRefGoogle Scholar
  11. Klein AW, Rish DC (1984) Injectable collagen update. J Dermatol Surg Oncol 10: 519–522PubMedCrossRefGoogle Scholar
  12. Knapp TR, Luck E, Daniels JR (1977) Behaviour of solubi- lized collagen as a bioimplant. J Surg Res 233: 96–105CrossRefGoogle Scholar
  13. Landes E (1985) Die Anwendung von and Erfahrung mit Collagen bei der Behandlung von Falten and Narben. Z Hautkr 60: 1255–1269PubMedGoogle Scholar
  14. Moscona RR, Bergman R, Friedman-Birnbaum R (1993) An unusual late reaction to Zyderm I injections: a challenge for treatment. Plast Reconstr Surg 92: 331–334PubMedCrossRefGoogle Scholar
  15. Petres J, Konz B, Landes E (1987) Injizierbares Kollagen. In: Petres J (Hrsg) Aktuelle Behandlungsverfahren. Springer, Berlin Heidelberg New York Tokyo (Fortschritte der operativen Dermatologie, Bd 3 ), S 170–180Google Scholar
  16. Petres J, Müller RPA (1988) Indikationen und Grenzen von Kollagen-Implantationen in der Dermatologie. In: Haneke E (Hrsg) Gegenwärtiger Stand der operativen Dermatolgie. Springer, Berlin Heidelberg New York Tokyo (Fortschritte der operativen Dermatologie, Bd 4 ), S 295–302 )Google Scholar
  17. Pollack SV (1990) Silicone, fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol 16: 957–961PubMedCrossRefGoogle Scholar
  18. Siegle RJ, McCoy JP Jr, Schade W, Swanson NA (1984) Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions. Arch Dermatol 120: 183–187PubMedCrossRefGoogle Scholar
  19. Soo C, Rahbar G, Moy RL (1993) The immunogenicity of bovine collagen implants. J Dermatol Surg Oncol 19: 431–434PubMedCrossRefGoogle Scholar
  20. Spira M, Liu B, Xu Z, Harrell R, Chahadeh H (1994) Human amnion collagen for soft tissue augmentation–biochemical characterizations and animal observations. J Biomed Mater Res 28: 91–96PubMedCrossRefGoogle Scholar
  21. Stegman SJ, Tromovitch TA (1980) Implantation of collagen for depressed scars. J Dermatol Surg Oncol 6: 450–453Google Scholar
  22. Stoner JG, Swanson NA, Siegle RJ (1984) Treatment of localized morphea with Zyderm collagen implant. J Dermatol Surg Oncol 10: 626–627PubMedCrossRefGoogle Scholar
  23. Swanson NA, Stoner JG, Siegle RJ, Solomon AR (1983) Treatment site reactions to Zyderm Collagen Implantation. J Dermatol Surg Oncol 9: 377–380PubMedCrossRefGoogle Scholar
  24. Trautinger F, Kokoschka EM, Menzel EJ (1991) Antibody formation against human collagen and Ciq in response to a bovine collagen implant. Arch Dermatol Res 283: 395–359PubMedCrossRefGoogle Scholar
  25. Tromovitch TA, Stegman SJ, Glogau RG (1984) Zyderm collagen: implantation technics. J Am Acad Dermatol 10: 273–278PubMedCrossRefGoogle Scholar
  26. Varnavides CK, Forster RA, Cunliffe WJ (1987) The role of bovine collagen in the treatment of acne scars. Br J Dermatol 116: 199–206PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • Johannes Petres
    • 1
  • Rainer Rompel
    • 1
  1. 1.HautklinikStädtischen Kliniken KasselKasselDeutschland

Personalised recommendations